SELLAS Life Sciences (SLS) Gross Profit (QoQ) (2013 - 2021)

SELLAS Life Sciences (SLS) Gross Profit (QoQ) (2013 - 2021) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 SELLAS Life Sciences 3.23 Mn 3.23 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2021 -67.86%
Mar 31, 2021 194.74%
Jun 30, 2015 23.63%
Mar 31, 2015 -13.25%
Dec 31, 2014 97.89%
Sep 30, 2014 -30.80%
Jun 30, 2014 7.71%
Mar 31, 2014 -37.20%
Dec 31, 2013 237.51%
Sep 30, 2013 -62.72%
Jun 30, 2013 7.27%
Mar 31, 2013 285.73%